Head-to-head · WeighScore
yourEra vs YOURx Health
The verdict
yourEra takes it — 83.8/100 to 70/100.
yourEra grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A both-molecule compounded program that publishes its prices up front — semaglutide $199/mo, tirzepatide $299/mo — across a 50-state clinician network, with an optional coaching-plus-labs membership and a NAD+/microdosing menu on the side.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | yourEra | YOURx Health |
|---|---|---|
| WeighScore | 83.8/100 | 70/100 |
| Grade | B | C |
| Scorecard rank | #13 | #109 |
| Semaglutide | $199/mo | $179/mo (compounded) |
| Tirzepatide | $299/mo | $199/mo (compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #13 · B
Strengths
- Transparent, publicly listed pricing — many compounded competitors hide price behind a quiz
- Both semaglutide and tirzepatide, not a single-drug menu, plus NAD+ and microdosing lines
- Markets a 50-state licensed-clinician network; no insurance required, HSA/FSA accepted
- Optional yourEra Optimum membership adds 1:1 coaching, a nutritionist, at-home lab draws and wearables
Where it loses points
- Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
- Mid-market pricing ($199 sema / $299 tirz) — above the cheapest compounders
- No brand-name lane and no oral route — weekly injectable only
- Thin independent footprint; the 50-state and efficacy claims are self-reported
Graded #109 · C
Strengths
- Lab monitoring included (per the home page) — most peer platforms gate labs as add-ons or skip them entirely
- Physician video consultation with 'board-certified provider' disclosed
- MD Integrations network is a recognized white-label clinical platform
- Transparent published pricing: semaglutide injection $179/mo, tirzepatide injection $199/mo, oral RDT tablets $159-$179/mo
Where it loses points
- Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
- NO LegitScript / NABP / PCAB / BBB seal displayed — material trust-signal gap vs peer platforms
- Per-state availability shown as 'Coverage 0 States' (placeholder metric) — appears the home page is incomplete or the platform is pre-launch
- Pharmacy partners NOT publicly named
- Confidence LOW until the platform exposes more public information
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.